Aurora Board Rejects Revised Curaleaf Bid, Opens Strategic Review
Edmonton – October 14, 2026 -- Aurora Cannabis' board unanimously recommended that shareholders reject Curaleaf Holdings' revised hostile offer, which remains open until December 4, 2026, and said its special committee is actively exploring alternatives, including a deal with one or more third parties.
The recommendation, made on the unanimous advice of a special committee of independent directors, responds to the Notice of Variation, Change and Extension that Curaleaf filed on October 6, 2026. Aurora's financial advisor delivered an updated opinion concluding that the revised consideration is inadequate, from a financial point of view, to Aurora shareholders.
Board says revised offer shifts risk and cost onto Aurora shareholders
Aurora argues that the increase in consideration consists principally of Curaleaf shares at an inflated valuation. Aurora shareholders would therefore stay fully exposed to any decline in the Curaleaf share price.